Albany, NY -- (SBWIRE) -- 12/02/2013 -- Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat

, "Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 – Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat", which provides insights into three cardiovascular therapeutic indications in the top eight markets of the US, the UK, Germany, France, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indications.

To check out the complete table of contents, visit: http://www.marketresearchreports.biz/analysis-details/cardiovascular-diseases-therapeutics-in-major-developed-markets-to-2019-increasing-prevalence-and-promising-novel-drugs-offset-patent-cliff-threat

Scope

Disease overview and treatment usage patterns
Market size and forecast for heart failure, Myocardial Infarction (MI) and Acute Coronary Syndrome (ACS)
Geographic coverage includes the top eight markets (the US, the UK, Germany, France, Italy, Spain, Japan and Canada) from 2012 to 2019
Major marketed products for the indications types covered
In-depth pipeline analysis for heart failure, MI and ACS
Key drivers and restraints that have had and are expected to have a significant impact upon the market
Key licensing and co-development agreements in the cardiovascular market

Reasons to Buy

The report will enhance your decision-making capability by allowing you to:

Align your product portfolio to the markets with high growth potential
Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the cardiovascular market
Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/179963

Table of Content

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 GBI Research Report Guidance

3 Therapeutic Landscape
3.1 Heart Failure
3.1.1 Symptoms
3.1.2 Etiology
3.1.3 Pathophysiology
3.1.4 Co-morbidities and Complications
3.1.5 Diagnosis
3.1.6 Classification
3.1.7 Prognosis and Disease Staging
3.1.8 Treatment Options
3.2 Myocardial Infarction
3.2.1 Symptoms
3.2.2 Etiology
3.2.3 Pathophysiology
3.2.4 Co-morbidities and Complications
3.2.5 Diagnosis
3.2.6 Classification
3.2.7 Treatment Options
3.3 Acute Coronary Syndrome
3.3.1 Symptoms
3.3.2 Etiology
3.3.3 Pathophysiology
3.3.4 Diagnosis
3.3.5 Treatment Options

4 Marketed Products
4.1 Heart Failure
4.2 Myocardial Infarction
4.3 Acute Coronary Syndrome
4.4 Key Marketed Products
4.4.1 Arixtra
4.4.2 Brilinta
4.4.3 Crestor
4.4.4 Diovan and Diovan HCT/Co-Diovan
4.4.5 Atacand
4.4.6 Lipitor
4.4.7 Clopidogrel bisulfate
4.4.8 Angiomax
4.4.9 Lovenox
4.4.10 Norvasc
4.4.11 Coreg
4.4.12 Ivabradine
4.4.13 Toprol-XL

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/179963

5 Pipeline Analysis
5.1 Heart Failure Pipeline
5.1.1 Overall Pipeline
5.1.2 Pipeline Analysis by Molecule Type
5.1.3 Pipeline Analysis by Mechanism of Action
5.2 Myocardial Infarction Pipeline
5.2.1 Overall Pipeline
5.2.2 Pipeline Analysis by Molecule Type
5.2.3 Pipeline Analysis by Mechanism of Action
5.3 Acute Coronary Syndrome Pipeline
5.3.1 Overall Pipeline
5.3.2 Pipeline Analysis by Molecule Type
5.3.3 Pipeline Analysis by Mechanism of Action
5.4 Promising Drug Candidates in the Pipeline
5.4.1 LCZ-696
5.4.2 Darapladib (SB-480848)
5.4.3 Neucardin
5.4.4 Cangrelor
5.4.5 Serelaxin (Novartis AG)

6 Cardiovascular Diseases Global Market to 2019, Market Forecast
6.1 Global Market
6.1.1 Treatment Usage Patterns
6.1.2 Annual Cost of Treatment
6.1.3 Market Size
6.2 US
6.2.1 Treatment Usage Patterns
6.2.2 Annual Cost of Treatment

Latest Reports:

Nonylphenol Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/nonylphenol-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Nonylphenol is a viscous liquid, soluble in oil and organic solvents and insoluble in water. Nonylphenol is used mainly for the production of non-ionic surfactants. It is also used in production of phenolic resins and epoxy. It is used as a supplement for greases, for production of agro-chemicals and in the tyre industry. Nonylphenols are used in industrial and domestic cleaning chemicals, textile and leather processing, cosmetics, paints, metal cutting, pulp and paper industry, agricultural products and in the plastics industry.

Nonylphenol salts of Barium as well as calcium have application as heat stabilizers in plastic. Nonylphenol phosphate esters are used to retard flame. Nonylphenol is raw material for Nonlyphenol ethoxylate which is used in Surfactants. United States, Europe, China and Japan are among the largest manufacturers of Nonylphenol. European countries have decreased their production due to NP being hazardous substance.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/179967

China is expected to drive the growth of Nonylphenol market in the near future on account of the growing population and acceptance by various industries like textiles and leather, polymers and metals. There is decreasing trend of demand in Europe due to its involvement in list A priority hazardous substance by REACH. In addition to this growing innovation in Nonylphenols, production is expected to open new opportunities for the market.

Some of the key players in NonylPhenol market are Sasol Germany GmbH, Polimeri Europe, Synteza, Hangzhou Ruijiang Chemical Co., Ltd., and Dow chemical.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

Propionic Acid and Derivatives Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/propionic-acid-and-derivatives-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

Propionic acid is a three-carbon carboxylic acid manufactured by the hydrocarboxylation of ethylene with the inclusion of a nickel carbonyl catalyst. It prevents the growth of some bacteria and mold due to which it is widely used as preservatives for food for human consumption and animal feed. In addition, it is used to make specialized propionates such as acetate propionate used as thermoplastics. Other applications of propionic acid and derivatives include solvents, and herbicides. Derivatives of propionic acid such as ibuprofen and fenoprofen are widely used in the pharmaceutical industry.

The global industry for propionic acid & derivatives has grown considerably during the past few years and is expected to continue the same trend in the forecast period owing to the growing demand for food preservations, grain preservations and feed preservations. Europe was the largest market of propionic acid & derivatives mostly driven by the ban imposed on the antibiotics in pharmaceutical applications. In addition, the demand for propionic acid & derivatives in the European region is expected to remain strong with the huge demand in the grain and feed preservatives segment. Europe was followed by North America and Asia Pacific with U.S. being the largest single market for propionic acid & derivatives across the globe.

Factors such as growing demand for safe grain and feed preservations are expected to fuel the future growth for the propionic acid and derivatives market. In addition, changing lifestyle has also led to rising demand to augment the shelf life of food products thereby increasing the food preservatives demand, including propionates. However, rising health concerns due to exposure of propionic acid and derivatives causing irritation to skin and eyes has led to continuous monitoring by various health organizations. Niacet Corporation, Eastman Chemical, Perstorp, The Dow Chemical Company, and BASF SE are some of the major players dominating the propionic acid and derivatives industry.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/toc/179969

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

About MarketResearchReports.Biz
MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
Blog: http://industry-research-reports.blogspot.com/